New Zealand markets open in 8 hours 53 minutes

Atara Biotherapeutics Inc (AT2.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
8.800.00 (0.00%)
As of 06:17PM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
34,704
8,573
63,573
20,340
0
Cost of revenue
10,655
8,886
0
-
-
Gross profit
24,049
-313
63,573
-
-
Operating expenses
Research development
208,135
224,785
272,533
282,001
244,650
Selling general and administrative
48,149
50,908
71,553
78,801
64,402
Total operating expenses
256,284
275,693
344,086
360,802
309,052
Operating income or loss
-232,235
-276,006
-280,513
-340,462
-309,052
Interest expense
5,102
5,285
373
-
-
Total other income/expenses net
19
-246
49,537
-
-
Income before tax
-233,090
-276,111
-228,290
-340,095
-306,605
Income tax expense
17
15
12
46
15
Income from continuing operations
-233,107
-276,126
-228,302
-340,141
-306,620
Net income
-233,107
-276,126
-228,302
-340,141
-306,620
Net income available to common shareholders
-233,107
-276,126
-228,302
-340,141
-306,620
Basic EPS
-2.78
-2.61
-2.24
-3.63
-4.15
Diluted EPS
-2.78
-2.61
-2.24
-3.63
-4.15
Basic average shares
104,670
105,912
101,990
93,670
73,973
Diluted average shares
104,670
105,912
101,990
93,670
73,973